novo nordisk wegovy ozempic news

Novo Nordisk, Wegovy

Ozempic, Wegovy sales inject wealth into Novo Nordisk home country of Denmark

Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide— while adding great heft to the economy of Novo Nordisk's home country, Denmark.

Yahoo · 1d

Wegovy sales are slaying for Novo Nordisk right now

Sales of Novo Nordisk’s (NVO) blockbuster weight loss drug Wegovy continue to soar, surpassing Wall Street expectations. The Danish pharma giant posted its third-quarter earnings report early Tuesday morning and boasted sales figures blowing past analysts’ projections.

Bloomberg on MSN · 1d

Novo Nordisk’s Wegovy Sales Increase Reassures Investors

Novo Nordisk A/S shares rose as surging sales of the blockbuster weight-loss treatment Wegovy reassured investors after rival Eli Lilly & Co. reported disappointing sales of its obesity treatment last week.

Compounded Ozempic tied to deaths, hospitalizations

San Francisco Examiner · 19h

Novo Nordisk CEO Warns of Deaths Linked to Compounded Semaglutide

THURSDAY, Nov. 7, 2024 (HealthDay News) -- The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned ... I’m quite alarmed by what we see in the U.S. now,” Novo Nordisk President and CEO Lars Fruergaard Jorgensen ...

Becker's Hospital Review · 3h

Compounded Ozempic tied to deaths, hospitalizations: Novo Nordisk CEO

Semaglutide has been on the FDA's shortage list since 2022, which has enabled compounding pharmacies and manufactures to make their own, unapproved versions of the drug. Novo Nordisk in October requested the FDA block compounding pharmacies from producing versions of the drug, saying semaglutide is too complex for others to replicate safely.

Benzinga.com · 5h

Compounded Versions Of Weight Loss And Diabetes Drugs Led To Death And Hospitalization, Novo Nordisk Says It Is Aware

Novo Nordisk addresses safety concerns surrounding compounded versions of its weight-loss and diabetes drugs, including reports of deaths and hospitalizations, while working with the FDA to resolve issues.

3don MSN

Scientist behind Novo Nordisk's Ozempic, Wegovy started her career developing laundry detergent

Novo Nordisk scientist Lotte Knudsen, whose research led to Ozempic and Wegovy, started her career developing laundry ...

FiercePharma1d

After Lilly's GLP-1 sales fumble, Novo reports mixed results on Ozempic, Wegovy

Following a disappointing earnings showing from Eli Lilly last week, Novo Nordisk’s latest report on the performance of its ...

1don MSN

Novo Nordisk shares jump 8% after Wegovy sales beat expectations

Novo Nordisk on Wednesday reported third quarter earnings broadly in line with expectations, said that its net profit in the ...

NBC Los Angeles1d

Novo Nordisk quarterly profit meets expectations as Wegovy maker narrows full-year guidance

Novo Nordisk on Wednesday reported third quarter earnings broadly in line with expectations and narrowed its 2024 full-year ...

Ozempic/Wegovy Maker Maintains Q3 Sales Growth On Booming Demand

On Wednesday, Novo Nordisk A/S (NYSE:NVO) reported third-quarter 2024 sales of 71.311 billion Danish kroner (around $10.3 ...

2don MSN

What Wall Street Analysts Think of Novo Nordisk's Stock Ahead of Earnings

Novo Nordisk reports earnings Wednesday morning, with sales of blockbuster weight-loss drugs Ozempic and Wegovy expected to continue driving the Danish drugmaker's results higher.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results